Precision Medicine Academy
Navigating Cancer Precision Medicine
Navigating Cancer Precision Medicine was designed to give healthcare providers with little to no background in genomics an overview of how genomics is being applied to cancer care. Through the course, learners will increase their awareness, improve their genomic literacy and gain important skills for navigating this rapidly evolving field. After taking this course, learners should be able to:
- Recognize patients who would benefit from hereditary cancer testing.
- Recognize patients who would benefit from tumor molecular profiling.
- Distinguish whether a given genetic test examines germline DNA variants, somatic variants or gene expression.
- Describe how knowledge of a cancer patient’s tumor molecular profile can impact treatment decisions.
- Identify major drawbacks of using very large gene panels for hereditary or somatic testing.
- Specify three benefits of hereditary cancer testing of a person who already has cancer.
- Define some current and future uses of liquid biopsies.
- Demonstrate an understanding of the meaning of a test result indicating a variant of uncertain significance.
- Discuss the shortcomings of some direct-to-consumer hereditary cancer tests.
- Outline some of the potential risks of genetic testing.
A certificate of completion is available at the end of the course. Users will need to register on the site, but the course is free for those with this link:
This course is provided through an education grant from the Illumina Corporate Foundation.